(ANDA) |
| 0 (0%) 10-10 16:16 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 10.70 |
| Resistance 1: | 9.94 |
| Pivot price: | 9.97 |
| Support 1: | 8.70 |
| Support 2: | 7.24 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.640 |
| Book Value | -0.570 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -1.8 |
| Return on Equity (ttm) | -168.1 |
Company news
Wed, 08 Oct 2025
FDA Launches New ANDA Prioritization Pilot to Support U.S.-Based Generic Manufacturing - The National Law Review
Wed, 08 Oct 2025
Rylee + Cru Unifies Three Brands and Expands Into Retail while Maintaining 25% Ecommerce Growth - Shopify
Mon, 06 Oct 2025
FDA's New ANDA Prioritization Pilot Signals Major Shift - openPR.com
Mon, 06 Oct 2025
US FDA’s ANDA Prioritization Pilot Encouraging Production Onshoring - insights.citeline.com
Mon, 06 Oct 2025
FDA backs generics onshoring push with ANDA priority scheme - Pharmaceutical Technology
Sat, 04 Oct 2025
New ANDA prioritization pilot to support US generic drugs - The Pharma Letter
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
